NEWS & VIEWS
APeX Institute Researchers have been invited as Key Note
Speakers to present APeX Direct Cellular Oxygen Infusion
Protocol to the prestigious 2018 International Conference
on Cancer Diagnosis and Treatment in Oslo, Norway!
Hypoxic Micro-Environments may be the Primary Driver of Uncontrollable Tumor Growth;
1. Hypoxia induced changes in cancer cells can increase resistance to conventional therapies.
2. With Hypoxia identified as a key driver for the growth and spread of cancer (Merck Drugs - 2011), APeX Direct Cellular Oxygen Infusion appears to be an effective break-through therapy.
3. APeX Autonomous Oxygen Delivery Nano-Clusters deliver active oxygen molecules directly into the cancer cells hypoxic micro-environment, dramatically reducing or eliminating the hypoxic condition in which cancer cells thrive.
APeX Institute Press Release for London Invitation.